Burcon NutraScience Corporation
BU.TO · TSX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 106.9% | -49.3% | 112.2% | – |
| Cost of Goods Sold | CA$1 | CA$0 | CA$0 | CA$0 |
| Gross Profit | -CA$1 | CA$0 | CA$0 | CA$0 |
| % Margin | -228.3% | 100% | 100% | 100% |
| R&D Expenses | CA$3 | CA$3 | CA$4 | CA$3 |
| G&A Expenses | CA$4 | CA$4 | CA$4 | CA$4 |
| SG&A Expenses | CA$4 | CA$4 | CA$4 | CA$4 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | -CA$1 | -CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$7 | CA$7 | CA$8 | CA$8 |
| Operating Income | -CA$8 | -CA$7 | -CA$8 | -CA$7 |
| % Margin | -2,018.8% | -4,055.6% | -2,067.9% | -4,314.2% |
| Other Income/Exp. Net | -CA$1 | CA$0 | -CA$18 | -CA$3 |
| Pre-Tax Income | -CA$8 | -CA$7 | -CA$25 | -CA$10 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$8 | -CA$7 | -CA$25 | -CA$10 |
| % Margin | -2,167% | -4,039% | -6,969.9% | -5,982.6% |
| EPS | -1.06 | -0.031 | -0.11 | -0.047 |
| % Growth | -3,364.1% | 72.2% | -133.1% | – |
| EPS Diluted | -1.06 | -0.031 | -0.11 | -0.047 |
| Weighted Avg Shares Out | 8 | 243 | 217 | 217 |
| Weighted Avg Shares Out Dil | 8 | 243 | 217 | 217 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$1 | CA$1 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$1 | CA$1 | CA$0 |
| EBITDA | -CA$7 | -CA$6 | -CA$19 | -CA$10 |
| % Margin | -1,949.3% | -3,380% | -5,194.7% | -5,787.8% |